Association between pan-immune-inflammation value and heart failure: Evidence from the NHANES 2011–2020
Objective This study aimed to explore the association between pan-immune-inflammation value and heart failure outcomes using data from the nationally representative National Health and Nutrition Examination Survey database. Methods We conduct a cross-sectional cohort analysis using National Health a...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-03-01
|
| Series: | Journal of International Medical Research |
| Online Access: | https://doi.org/10.1177/03000605251325176 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850051440080322560 |
|---|---|
| author | Chen Fu Yijie Mao |
| author_facet | Chen Fu Yijie Mao |
| author_sort | Chen Fu |
| collection | DOAJ |
| description | Objective This study aimed to explore the association between pan-immune-inflammation value and heart failure outcomes using data from the nationally representative National Health and Nutrition Examination Survey database. Methods We conduct a cross-sectional cohort analysis using National Health and Nutrition Examination Survey data, including participants aged ≥20 years with available pan-immune-inflammation value data. We performed smooth curve fitting and threshold analysis, using both linear and non-linear regression models, to assess dose–response relationship and explore the continuous effect of pan-immune-inflammation value on heart failure outcomes. Results Our analysis revealed a significant and independent non-linear association between elevated pan-immune-inflammation value levels and an increased risk of heart failure occurrence. After adjustment for multiple covariates, these findings remained consistent and each increment unit in logarithmic pan-immune-inflammation value is associated with 34% increase in the risk of heart failure occurrence. Furthermore, we identified an inflection point of logarithmic pan-immune-inflammation value = 5.98 as a critical threshold. Stratified analyses revealed that the association between pan-immune-inflammation value and heart failure occurrence remains consistent across different subgroups. Conclusions This study confirmed the clinical value of pan-immune-inflammation value as a novel inflammatory biomarker in the assessment and monitoring of heart failure. |
| format | Article |
| id | doaj-art-17eaa494c0224624be373c0f2d786e2e |
| institution | DOAJ |
| issn | 1473-2300 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Journal of International Medical Research |
| spelling | doaj-art-17eaa494c0224624be373c0f2d786e2e2025-08-20T02:53:09ZengSAGE PublishingJournal of International Medical Research1473-23002025-03-015310.1177/03000605251325176Association between pan-immune-inflammation value and heart failure: Evidence from the NHANES 2011–2020Chen FuYijie MaoObjective This study aimed to explore the association between pan-immune-inflammation value and heart failure outcomes using data from the nationally representative National Health and Nutrition Examination Survey database. Methods We conduct a cross-sectional cohort analysis using National Health and Nutrition Examination Survey data, including participants aged ≥20 years with available pan-immune-inflammation value data. We performed smooth curve fitting and threshold analysis, using both linear and non-linear regression models, to assess dose–response relationship and explore the continuous effect of pan-immune-inflammation value on heart failure outcomes. Results Our analysis revealed a significant and independent non-linear association between elevated pan-immune-inflammation value levels and an increased risk of heart failure occurrence. After adjustment for multiple covariates, these findings remained consistent and each increment unit in logarithmic pan-immune-inflammation value is associated with 34% increase in the risk of heart failure occurrence. Furthermore, we identified an inflection point of logarithmic pan-immune-inflammation value = 5.98 as a critical threshold. Stratified analyses revealed that the association between pan-immune-inflammation value and heart failure occurrence remains consistent across different subgroups. Conclusions This study confirmed the clinical value of pan-immune-inflammation value as a novel inflammatory biomarker in the assessment and monitoring of heart failure.https://doi.org/10.1177/03000605251325176 |
| spellingShingle | Chen Fu Yijie Mao Association between pan-immune-inflammation value and heart failure: Evidence from the NHANES 2011–2020 Journal of International Medical Research |
| title | Association between pan-immune-inflammation value and heart failure: Evidence from the NHANES 2011–2020 |
| title_full | Association between pan-immune-inflammation value and heart failure: Evidence from the NHANES 2011–2020 |
| title_fullStr | Association between pan-immune-inflammation value and heart failure: Evidence from the NHANES 2011–2020 |
| title_full_unstemmed | Association between pan-immune-inflammation value and heart failure: Evidence from the NHANES 2011–2020 |
| title_short | Association between pan-immune-inflammation value and heart failure: Evidence from the NHANES 2011–2020 |
| title_sort | association between pan immune inflammation value and heart failure evidence from the nhanes 2011 2020 |
| url | https://doi.org/10.1177/03000605251325176 |
| work_keys_str_mv | AT chenfu associationbetweenpanimmuneinflammationvalueandheartfailureevidencefromthenhanes20112020 AT yijiemao associationbetweenpanimmuneinflammationvalueandheartfailureevidencefromthenhanes20112020 |